Clinical Trials Directory

Trials / Terminated

TerminatedNCT02710877

Intermittent Automated Devices for Labor Analgesia in Emilia Romagna

Pain Management During Labor: Use of Intermittent Drug Delivery Devices for Obstetric and Neonatal Outcome Improvement and Health-care Burden Reduction

Status
Terminated
Phase
N/A
Study type
Interventional
Enrollment
671 (actual)
Sponsor
University of Modena and Reggio Emilia · Academic / Other
Sex
Female
Age
18 Years
Healthy volunteers
Not accepted

Summary

The study aims to determine whether the use of automated intermittent devices for labor analgesia could prevent the increase of instrumental deliveries, with same analgesia. Moreover it will evaluate if automated devices can allow a reduction of health-care burden.

Detailed description

Epidural analgesia is recognized as the most effective technique to control labor pain, although its possible adverse events. Continuous epidural administration of local anesthetics can stabilize the analgesic block and reduce the anesthesiologists' workload but is associated with an increase in operative vaginal delivery. Epidural intermittent boluses performed by anesthetist are associated to reduction of dosages, but they could provide insufficient analgesia and they involve the constant anesthetist's presence in the operating room. This is a multicenter randomized controlled trial with two arms, funded by grant of Regione Emilia Romagna, in which we will compare two different epidural analgesia protocols: anesthesiologist's supervised versus intermittent boluses with PCEA.

Conditions

Interventions

TypeNameDescription
DEVICEProgrammed Intermittent bolusProgrammed epidural bolus of 10 ml mixture every 75 minutes, plus patient controlled bolus of 5 ml same mixture; lock-out 15 minutes.
OTHERManual epidural bolusEpidural bolus of 15 ml levobupivacaine and sufentanyl 10 mcg or 5 mcg administered by anesthesist on maternal request.
DRUGLevobupivacaineLevobupivacaine 0,0625% through peridural catheter
DRUGSufentanil 4 mcgSufentanil 0,4 mcg/ml through peridural catheter
DRUGSufentanil 5 mcgSufentanil 5 mcg through peridural catheter

Timeline

Start date
2014-12-23
Primary completion
2017-12-27
Completion
2018-02-28
First posted
2016-03-17
Last updated
2018-03-27

Locations

3 sites across 1 country: Italy

Source: ClinicalTrials.gov record NCT02710877. Inclusion in this directory is not an endorsement.